Skip to content

Efficacy of Ultrasound-Guided Spinal Nerve Electrical Stimulation Combined with CT-Guided Pulsed Radiofrequency of Dorsal Root Ganglion in Treating Postherpetic Neuralgia and Its Impact on CD4+ and CD8+ T Lymphocytes

Efficacy of Ultrasound-Guided Spinal Nerve Electrical Stimulation Combined with CT-Guided Pulsed Radiofrequency of Dorsal Root Ganglion in Treating Postherpetic Neuralgia and Its Impact on CD4+ and CD8+ T Lymphocytes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117925
Enrollment
Unknown
Registered
2026-01-30
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic Neuralgia

Interventions

group P:CT-Guided Pulsed Radiofrequency of the Dorsal Root Ganglion
group U:Ultrasound-Guided Electroacupuncture Stimulation Combined with CT-Guided Pulsed Radiofrequency of the Dorsal Root Ganglion

Sponsors

The Affiliated Hospital of Putian University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. A clear history of herpes zoster (HZ), with pain persisting for >= 1 month after the skin lesions have healed; 2. Age >= 40 years and = 4 on the Visual Analogue Scale (VAS); 4. The patient and their family members were informed and provided consent, agreed to receive the treatment regimen of this study, and signed the treatment informed consent form

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiovascular or cerebrovascular diseases, or insufficiency of the lungs, liver, or kidneys; 2. Patients with severe psychiatric or psychological disorders; 3. Patients with coagulation dysfunction; 4. Patients with metallic implants, cardiac pacemakers, or defibrillators; 5. Patients with infection at the puncture site; 6. Patients with needle phobia or allergy to the therapeutic drugs; 7. Patients with a history of malignant tumors; 8. Pregnant or lactating women; 9. Patients with immunodeficiency or those on long-term immunosuppressive therapy; 10. Patients with poor compliance, unwillingness to follow medical advice, or refusal to attend follow-up visits

Design outcomes

Primary

MeasureTime frame
VAS Score;

Secondary

MeasureTime frame
Treatment Effective Rate;Pittsburgh sleep quality index,PSQI;self-rating anxiety scale, SAS;CD4+, CD8 +, CD4 +/CD8+;Analgesic Consumption;Adverse reactions;self-rating depression scale,SDS;

Countries

China

Contacts

Public ContactXinqiang Lin

The Affiliated Hospital of Putian University

894651884@qq.com+86 136 4698 3330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026